Camp4 Therapeutics: JPMorgan Upgrade and Progress on CMP-002 Highlight RNA Pioneer

The Business Model of Targeted Gene Upregulation Camp4 Therapeutics (CAMP) is a biopharmaceutical company in the clinical development phase, aiming for a paradigm shift in the treatment of genetic diseases. While previous RNA therapy research primarily focused on "silencing" disease-causing genes (Gene Silencing), Camp4 takes the opposite approach: the targeted upregulation of gene expression. At the core of the business model is the proprietary RAP Platform (Regulatory RNA Activating Platform). This technology platform combines high-throughput...